Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical efficacy and economic value of insulin lispro 25-Prandilin 25 versus insulin 25-Humalog mixture 25 mg in treatment of newly diagnosed type 2 diabetes mellitus by a continuous glucose monitoring system

Trial Profile

Clinical efficacy and economic value of insulin lispro 25-Prandilin 25 versus insulin 25-Humalog mixture 25 mg in treatment of newly diagnosed type 2 diabetes mellitus by a continuous glucose monitoring system

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2018

At a glance

  • Drugs Insulin lispro (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Dec 2018 New trial record
    • 01 Dec 2018 Results published in the Diabetes Therapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top